Paper249793
Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.
Faville RJ and 5 others. JAMA, 1978. Cited by 167 papers, by iCite.
Cite this record
ConductScience Library. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. Papers, record 249793. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/249793
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endocarditis, Bacterial | Major topic |
| Rifampin | Major topic |
| Staphylococcal Infections | Major topic |
| Vancomycin | Major topic |
| Blood | |
| Child, Preschool | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Infant | |
| Male | |
| Methicillin | |
| Penicillin Resistance | |
| Sepsis | |
| Staphylococcus aureus |
Source PubMed
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 167 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30760474 | Methicillin-Resistant Staphylococcus aureus Prosthetic Valve Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management. | Clin Microbiol Rev | 2019 | https://conductscience.org/library/papers/30760474 | PubMed |
| 24775563 | Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin. | BMC Infect Dis | 2014 | https://conductscience.org/library/papers/24775563 | PubMed |
| 22553438 | Influence of rifampin therapy on serum bactericidal activity in the presence of cloxacillin and vancomycin. | Can J Infect Dis | 1990 | https://conductscience.org/library/papers/22553438 | PubMed |
| 21163725 | Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy. | Eur J Med Res | 2010 | https://conductscience.org/library/papers/21163725 | PubMed |
| 18474578 | Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18474578 | PubMed |
| 18159442 | The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper. | Can J Infect Dis | 2004 | https://conductscience.org/library/papers/18159442 | PubMed |
| 17712583 | Rifampin as adjuvant treatment of Gram-positive bacterial infections: a systematic review of comparative clinical trials. | Eur J Clin Microbiol Infect Dis | 2007 | https://conductscience.org/library/papers/17712583 | PubMed |
| 15509186 | Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. | Clin Pharmacokinet | 2004 | https://conductscience.org/library/papers/15509186 | PubMed |
| 15388469 | In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15388469 | PubMed |
| 15184410 | Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. | J Clin Microbiol | 2004 | https://conductscience.org/library/papers/15184410 | PubMed |
| 12709345 | Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/12709345 | PubMed |
| 11959588 | Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/11959588 | PubMed |
| 9371356 | Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9371356 | PubMed |
| 9336672 | Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. | Clin Microbiol Rev | 1997 | https://conductscience.org/library/papers/9336672 | PubMed |
| 9174189 | Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9174189 | PubMed |
| 8285624 | Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8285624 | PubMed |
| 8203842 | Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8203842 | PubMed |
| 7985998 | Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7985998 | PubMed |
| 7486895 | Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7486895 | PubMed |
| 7325636 | Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7325636 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/249793
GET https://conductscience.org/api/papers/v1/249793/cited_by?page=2